Cyclic peptide FXII inhibitor provides safe anticoagulation in a thrombosis model and in artificial lungs

Journal: Nature Communications

Published: 2020-08-04

DOI: 10.1038/s41467-020-17648-w

Affiliations: 4

Authors: 16

Go to article
Institutions Share
EPFL Institute of Chemical Sciences and Engineering (ISIC), Switzerland 0.44
Department of Biomedical Engineering, CMU, United States of America (USA) 0.31
Department of Clinical Research (DCR), UniBE, Switzerland 0.19
University Clinic of Hematology and Central Hematological Laboratory (UKH-HZL), UniBE, Switzerland 0.06

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER